LYCA
Lycia Therapeutics, Inc. Common Stock
Nasdaq · usd
Lycia Therapeutics, Inc. Common Stock (LYCA) trades at $26.95 (-6.59%) as of 12:38:42 PM EDT on Oct 27, 2026. Market cap is $1.5B.
Stock performance
How Lycia Therapeutics, Inc. Common Stock (LYCA) stock has performed from one day to one year, with its 52-week range.
- 1D
- -7.37%
- 1W
- —
- 1M
- —
- YTD
- -10.92%
- 1Y
- -10.92%
- 52-wk range
- $22.19 – $36.49
Key statistics
Today's trading snapshot for LYCA: day range, open, previous close, volume and market cap.
- Day range
- $24.63 – $28.00
- Open
- $26.51
- Prev close
- $28.85
- Volume
- 185.97K
- Market cap
- $1.5B
- Shares out
- 52.09M
8-K filings
Material corporate events Lycia Therapeutics, Inc. Common Stock has disclosed to the SEC on Form 8-K.
- Charter amendmentOct 26, 2026
On October 26, 2026, Lycia Therapeutics, Inc. (the "Company") filed its Amended and Restated Certificate of Incorporation (the "Charter") with the Secretary of State of the State of Delaware ... in connection with the closing of the initial public offering (the "Offering") of shares of the Company's common stock.
Frequently asked questions
What is the Lycia Therapeutics, Inc. Common Stock (LYCA) stock price today?
Lycia Therapeutics, Inc. Common Stock (LYCA) is trading at $26.95 (-6.59% on the day) as of 12:38:42 PM EDT on Oct 27, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Lycia Therapeutics, Inc. Common Stock?
Lycia Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, with an initial focus on addressing autoimmune, inflammatory and allergic diseases.
What exchange is LYCA listed on?
Lycia Therapeutics, Inc. Common Stock (LYCA) trades on Nasdaq in USD.
Build with AI
Build an analysis of LYCA with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a LYCA analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.